HARRISBURG – In response to the strain of our health care system and the importance of individual liberties, Sen. Doug Mastriano (R-33) introduced legislation allowing ivermectin to be available over the counter (OTC) in Pennsylvania.
Ivermectin is a safe and effective medication primarily used to treat parasitic infections, including onchocerciasis (river blindness), strongyloidiasis, scabies and lice. It has a long history of safe use.
“Why would we limit access to important medication when it’s so difficult to see a doctor? It’s ridiculous enough that people don’t have the individual liberty to treat themselves and their loved ones using effective medication that has already been approved by the Food and Drug Administration,” Mastriano said. “Making ivermectin available OTC would empower Pennsylvanians to manage their health with timely and cost-effective options.”
Senate Bill 601 would ensure that residents have faster access to ivermectin, reducing wait times and dependency on health care providers for conditions that do not require extensive medical consultation. Many Pennsylvanians, particularly in rural and underserved communities, struggle to access health care due to geographic, financial or logistical barriers. By making ivermectin available OTC, patients could self-administer the medication for common parasitic infections, saving both time and money while avoiding unnecessary doctor visits.
Ivermectin has been extensively studied and used for decades with limited side effects when adhering to medical guidelines. The risk of misuse is minimal for conditions like scabies and lice, where ivermectin’s topical formulations are highly effective and easy to apply.
Making ivermectin available OTC could also help control the spread of scabies and other parasitic diseases, especially in populations at higher risk of infection. Moreover, it could alleviate the burden on health care systems by preventing unnecessary emergency room visits or doctor appointments for conditions that can be easily managed with ivermectin.
Tennessee has already passed similar legislation to make ivermectin available OTC. Other states – such as Louisiana, South Carolina, Arkansas, Missouri, and Kansas – are currently considering similar initiatives. Many countries have implemented similar laws.
“It is time for Pennsylvania to join this important movement. With proven efficacy, a track record of safety and the growing demand for accessible treatments, making ivermectin available OTC would significantly benefit our communities,” Mastriano said.
CONTACT: Don Beishl, 717-787-6701